Evotec Enters into Long-Term Focused Library Agreement with Almirall
Value Exceeding EUR 2.5 m over the Two-Year Contract Period
Applying leading skills in high-speed parallel synthesis, medicinal and com-putational chemistry Evotec will design and synthesise for Almirall several thousand drug-like compounds across a wide range of chemical templates. With Evotec's state-of-the-art integrated autopurification and analytical plat-forms each compound will be of the highest purity to deliver high quality results in Almirall's pharmaceutical screening and medicinal chemistry pro-grammes.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.